Anti-fibrillization effects of sulfonamide derivatives on α-synuclein and hyperphosphorylated tau isoform 1N4R
Jessica S. Fortin(University of Arizona), Min‐Hao Kuo(Michigan State University), Hsiao-Tien Hagar(Michigan State University), Ulf Dettmer(Brigham and Women's Hospital), Babak Borhan(Karolinska Institutet), A. Prasanth Saraswati(University of Siena), Edmund L. Ellsworth(Pfizer (United States)), Soham Maity(Michigan State University), Scott Counts(Grand Rapids Community College), Susantha K. Ganegamage(New Mexico Institute of Mining and Technology), Mengyu Liu, Kuang‐Wei Wang(Michigan State University), Kazuma Shimanaka(Brigham and Women's Hospital)
Cited by 14
Related Papers
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306
Consensus statement: Standardized reporting of power-producing luminescent solar concentrator performance
|Joule|2022|145
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
|European Journal of Medicinal Chemistry|2017|119